Cargando…
Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma
BACKGROUND: RV1001 is a novel, potent, and selective PI3Kδ inhibitor. The purpose of this study was to evaluate the safety and efficacy of RV1001 in canine Non-Hodgkin lymphoma (NHL). METHODS AND RESULTS: Inhibition of endogenous pAKT by RV1001 in primary canine NHL cells was determined by Western b...
Autores principales: | Gardner, Heather L., Rippy, Sarah B., Bear, Misty D., Cronin, Kim L., Heeb, Heather, Burr, Holly, Cannon, Claire M., Penmetsa, Kumar V., Viswanadha, Srikant, Vakkalanka, Swaroop, London, Cheryl A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915681/ https://www.ncbi.nlm.nih.gov/pubmed/29689086 http://dx.doi.org/10.1371/journal.pone.0195357 |
Ejemplares similares
-
Simultaneous Quantification of Baricitinib and Methotrexate in Rat Plasma by LC-MS/MS: Application to a Pharmacokinetic Study
por: Veeraraghavan, Sridhar, et al.
Publicado: (2016) -
Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders
por: Routhu, Kasi Viswanath, et al.
Publicado: (2013) -
ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma
por: Cam, Maren, et al.
Publicado: (2016) -
A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma
por: Rippy, Sarah B., et al.
Publicado: (2016) -
Chemistry: 1,001 Practice Problems For Dummies
por: Hattori, Heather
Publicado: (2014)